P-161: Oral antivirals ritonavir-nirmatrelvir and molnupiravir are highly effective in patients with multiple myeloma and COVID-19; a singlecenter, prospective study
Title:
P-161: Oral antivirals ritonavir-nirmatrelvir and molnupiravir are highly effective in patients with multiple myeloma and COVID-19; a singlecenter, prospective study
Author:
Spiliopoulou, Vassiliki Ntanasis-Stathopoulos, Ioannis Malandrakis, Panagiotis Gavriatopoulou, Maria Theodorakakou, Foteini Fotiou, Despina Migkou, Magdalini Roussou, Maria Eleutherakis-Papaiakovou, Evangelos Kastritis, Efstathios Dimopoulos, Meletios A. Terpos, Evangelos